Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Typical schedule Many people use an initial loading phase, followed by maintenance injections every 46 weeks (subject to clinician review)
Clinical Trial Status: Where Each Compound Stands in 2026 Tirzepatide (Fully Approved) Tirzepatide completed its regulatory journey and received: FDA approval as Mounjaro (2022) for type 2 diabetes management FDA approval as Zepbound (2023) for chronic weight management in adults with obesity or overweight with weight-related comorbidities It is available via prescription from licensed healthcare providers in the United States and many other countries
Every lot, independently verified Compound information Chemical & structural reference data specifications, molecular profile and handling
I had back surgery September, 2022
US$ 29.76
US$ 24.14
US$ 21.32
US$ 29.33
